Alumis (ALMS) Cash from Operations (2023 - 2025)
Alumis (ALMS) reported Cash from Operations of 71907000.0 for Q4 2025, up 3.82% year-over-year from 69260315.48 in Q4 2024, and up 35.17% quarter-over-quarter from 110916000.0 in Q3 2025.
Alumis (ALMS) Cash from Operations (2023 - 2025) Analysis & Trends
Alumis (ALMS) has 3 years of Cash from Operations data on file, last reported at 71907000.0 in Q4 2025.
- Cash from Operations for Q4 2025 came in at 71907000.0, up 3.82% year-over-year; the trailing twelve-month figure through Dec 2025 was 369523000.0 (down 44.87% YoY), and the FY2025 annual result was 369523000.0, down 44.87% from the prior year.
- Cash from Operations improved to 71907000.0 in Q4 2025 per ALMS's latest filing, from 110916000.0 in the prior quarter.
- Over five years, Cash from Operations peaked at 33200000.0 in Q3 2023 and troughed at 110916000.0 in Q3 2025.
- A 3-year average of 69157600.0 and a median of 73335500.0 in 2024 frame the typical range for Cash from Operations.
- The sharpest annual moves came in 2024 and 2025: Cash from Operations tumbled 152.45% in 2024, then grew 3.82% in 2025.
- A 3-year view of Cash from Operations shows it stood at 33775000.0 in 2023, then plunged by 121.36% to 74764000.0 in 2024, then advanced by 3.82% to 71907000.0 in 2025.
- Business Quant data shows ALMS's Cash from Operations at 71907000.0 in Q4 2025, 110916000.0 in Q3 2025, and 106345000.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -1.67 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -12.20 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -2.49 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 1.43 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Alumis | 1.99 Bn | 1.90 Bn | - | -71.91 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -71.91 Mn |
| Dec 31, 2025 | -71.91 Mn |
| Sep 30, 2025 | -110.92 Mn |
| Sep 30, 2025 | -110.92 Mn |
| Jun 30, 2025 | -106.35 Mn |
| Jun 30, 2025 | -106.35 Mn |
| Mar 31, 2025 | -80.36 Mn |
| Mar 31, 2025 | -80.36 Mn |
| Dec 31, 2024 | -74.76 Mn |
| Dec 31, 2024 | -74.76 Mn |
| Sep 30, 2024 | -83.81 Mn |
| Sep 30, 2024 | -83.81 Mn |
| Jun 30, 2024 | -52.20 Mn |
| Jun 30, 2024 | -52.20 Mn |
| Mar 31, 2024 | -44.30 Mn |
| Mar 31, 2024 | -44.30 Mn |
| Dec 31, 2023 | -33.78 Mn |
| Dec 31, 2023 | -33.78 Mn |
| Sep 30, 2023 | -33.20 Mn |
| Sep 30, 2023 | -33.20 Mn |